scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1018807660 |
P356 | DOI | 10.1186/1471-230X-11-32 |
P932 | PMC publication ID | 3076249 |
P698 | PubMed publication ID | 21453541 |
P5875 | ResearchGate publication ID | 50938787 |
P2093 | author name string | Carlo Barone | |
Fabio M Vecchio | |||
Alessandro Inno | |||
Michele Basso | |||
Ettore D'Argento | |||
Eleonora Cerchiaro | |||
Cinzia Bagalà | |||
Valentina A Marsico | |||
P2860 | cites work | Histological grading and staging of chronic hepatitis | Q29619625 |
Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions | Q31368325 | ||
Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer | Q37276828 | ||
Adjuvant aromatase inhibitor therapy: outcomes and safety | Q37687585 | ||
Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries | Q40775438 | ||
Will steroidal aromatase inhibitors induce rheumatoid arthritis? | Q42844957 | ||
Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. | Q43050091 | ||
Simplified criteria for the diagnosis of autoimmune hepatitis | Q44425899 | ||
Joint pain with aromatase inhibitors: abnormal frequency of Sjögren's syndrome. | Q46950098 | ||
Pharmacokinetics and Metabolism of Bisoprolol Enantiomers in Humans | Q56620130 | ||
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial | Q59288489 | ||
Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase | Q73342193 | ||
Anastrozole-induced hepatotoxicity | Q79221962 | ||
Henoch-Schönlein purpura (HSP) during treatment with anastrozole | Q79249785 | ||
Severe acute hepatitis in a patient treated with anastrozole | Q79510296 | ||
P304 | page(s) | 32 | |
P577 | publication date | 2011-03-31 | |
P1433 | published in | BMC Gastroenterology | Q15759922 |
P1476 | title | Anastrozole-related acute hepatitis with autoimmune features: a case report | |
P478 | volume | 11 |
Q51004480 | A case of anastrazole-related drug-induced autoimmune hepatitis. |
Q34799879 | An unusual cause of jaundice in a patient with breast cancer |
Q37669293 | Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: A review |
Q38845891 | Drug-induced hepatotoxicity in cancer patients - implication for treatment |
Q38481053 | Hepatotoxicity of green tea: an update |
Q47099380 | Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature |
Q37067634 | Liver injury induced by anticancer chemotherapy and radiation therapy |
Q64227344 | Primary antiphospholipid syndrome during aromatase inhibitors therapy: A case report and review of the literature |
Q36333464 | The impact of Anastrazole and Letrozole on the metabolic profile in an experimental animal model. |